Military aviators, special operations forces, and causal malaria prophylaxis

Area of Science:

• Military medicine
• Tropical infectious diseases
• Pharmacology

Background:

• Current U.S. military malaria prophylaxis restricts aviators to chloroquine or doxycycline, while ground forces can also use mefloquine.
• Existing regimens require pre-deployment initiation and 4 weeks of medication post-deployment, including primaquine, leading to poor compliance.
• Frequent short-term overseas travel complicates adherence to lengthy prophylaxis schedules.

Purpose of the Study:

• To evaluate the potential benefits and drawbacks of causal malaria prophylaxis for U.S. military personnel.
• To explore alternatives to current lengthy malaria prevention regimens.
• To assess the feasibility of causal prophylaxis in military settings.

Main Methods:

• This abstract discusses a review of current malaria prophylaxis guidelines and potential alternative strategies.
• It considers the implications of causal prophylaxis on treatment duration and compliance.
• The analysis involves weighing potential benefits against risks such as adverse drug reactions and drug resistance.

Main Results:

• Causal malaria prophylaxis may shorten post-deployment treatment durations.
• It could eliminate the need for a separate terminal prophylaxis medication.
• Potential obstacles include adverse drug reactions, cost, and the development of Plasmodium resistance.

Conclusions:

• Causal malaria prophylaxis presents a potential improvement over current military malaria prevention strategies.
• Careful consideration of risks, including adverse effects and resistance, is crucial.
• Balancing these risks against health and mission success is essential for deployment planning.